Funder
Canadian Institutes of Health Research
Canada Research Chairs
Canada Research Chair in Drug Development
Subject
Molecular Biology,Biochemistry,Biophysics
Reference27 articles.
1. The actions of metabolic fate of disulfiram;Eneanya;Annu. Rev. Pharmacol. Toxicol.,1981
2. Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome;Cvek;Curr. Cancer Drug Targets,2011
3. The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor?;Cvek;Drug Discov. Today,2008
4. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies;Conticello;Int. J. Cancer,2012
5. A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites;Johansson;Acta Psychiatr. Scand.,1992
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献